Patent directory · USPTO A61K / A61P
Patents matching “Syndax Pharmaceuticals, Inc.”
6 pharma patents match "Syndax Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 6 pharmaceutical patents matching "Syndax Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12168054
Method of treating cancer using a combination of entinostat and an anti-CSF-1R antibody
granted -
US 12000829
Selection of patients for combination therapy
granted -
US 11919901
Inhibitors of the menin-MLL interaction
granted -
US 11397184
Selection of patients for combination therapy
granted -
US 11324822
Combination of HDAC inhibitor and anti-PD-1 antibody for treatment of cancer
granted -
US 10226472
Methods for the treatment of breast cancer
granted